Larimar Therapeutics (LRMR) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free LRMR Stock Alerts $6.46 0.00 (0.00%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Larimar Therapeutics Short Interest DataCurrent Short Volume3,190,000 sharesPrevious Short Volume1,630,000 sharesChange Vs. Previous Month+95.71%Dollar Volume Sold Short$24.21 millionShort Interest Ratio / Days to Cover5.5Last Record DateMarch 31, 2024Outstanding Shares63,800,000 sharesPercentage of Shares Shorted5.00%Today's Trading Volume222,439 sharesAverage Trading Volume556,179 sharesToday's Volume Vs. Average40% Short Selling Larimar Therapeutics ? Sign up to receive the latest short interest report for Larimar Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLRMR Short Interest Over TimeLRMR Days to Cover Over TimeLRMR Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Larimar Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20243,190,000 shares $24.21 million +95.7%N/A5.5 $7.59 3/15/20241,630,000 shares $14.18 million +221.6%N/A2.9 $8.70 2/29/2024506,800 shares $5.83 million -18.0%N/A1.1 $11.50 2/15/2024618,200 shares $8.21 million +82.0%3.5%1.5 $13.28 1/31/2024339,700 shares $1.97 million -4.9%N/A2.2 $5.79 1/15/2024357,100 shares $1.65 million -8.4%N/A2.8 $4.61 Get the Latest News and Ratings for LRMR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Larimar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023390,000 shares $1.77 million -4.0%N/A3 $4.55 12/15/2023406,100 shares $1.71 million -16.5%N/A4.1 $4.22 11/30/2023486,400 shares $1.67 million -7.8%N/A4.6 $3.43 11/15/2023527,400 shares $1.55 million -8.6%N/A4.8 $2.93 10/31/2023576,900 shares $1.69 million +0.2%N/A4.9 $2.93 10/15/2023575,600 shares $1.69 million -11.3%N/A2.7 $2.93 9/30/2023648,700 shares $2.56 million +7.9%N/A3.2 $3.95 9/15/2023601,100 shares $2.55 million -5.1%N/A2.9 $4.24 8/31/2023633,200 shares $2.36 million +9.9%N/A2.3 $3.72 8/15/2023576,200 shares $2.41 million -12.9%N/A2 $4.18 7/31/2023661,800 shares $2.83 million +3.8%N/A1.8 $4.28 7/15/2023637,500 shares $2.05 million +7.3%N/A2.3 $3.21 6/30/2023594,100 shares $1.86 million +296.3%N/A2.1 $3.13 6/15/2023149,900 shares $509,660.00 -23.9%N/A0.5 $3.40 5/31/2023197,000 shares $726,930.00 -12.0%N/A0.8 $3.69 5/15/2023223,800 shares $803,442.00 -14.3%N/A0.8 $3.59 4/30/2023261,000 shares $1.23 million -14.1%N/A1.2 $4.73 4/15/2023303,700 shares $1.38 million -1.2%N/A1.4 $4.53 3/31/2023307,500 shares $1.39 million -12.4%N/A1.5 $4.53 3/15/2023350,900 shares $2.03 million +3.0%N/A2 $5.79 2/28/2023340,600 shares $2.06 million +43.3%N/A1.9 $6.06 2/15/2023237,700 shares $1.41 million -6.2%N/A1.6 $5.93 1/31/2023253,300 shares $1.25 million -0.2%N/A2.2 $4.94 1/15/2023253,900 shares $1.18 million -1.1%N/A2.4 $4.65 12/30/2022256,800 shares $1.06 million -25.4%N/A2.4 $4.13 12/15/2022344,300 shares $1.57 million -9.7%N/A3 $4.56 11/30/2022381,300 shares $1.21 million +2.3%N/A2.2 $3.17 11/15/2022372,800 shares $1.13 million +12.5%N/A2.1 $3.03 10/31/2022331,500 shares $1.09 million +4.5%N/A1 $3.30 10/15/2022317,300 shares $970,938.00 -2.9%N/A1 $3.06 9/30/2022326,700 shares $1.05 million +17.8%N/A1 $3.20 9/15/2022277,300 shares $934,501.00 +2.0%1.6%0.9 $3.37 8/31/2022271,900 shares $739,568.00 -21.9%1.6%1.2 $2.72 8/15/2022347,900 shares $866,271.00 +93.0%2.0%1.7 $2.49This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry LRMR Short Interest - Frequently Asked Questions What is Larimar Therapeutics' current short interest? Short interest is the volume of Larimar Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 3,190,000 shares of LRMR short. Learn More on Larimar Therapeutics' current short interest. What is a good short interest ratio for Larimar Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LRMR shares currently have a short interest ratio of 6.0. Learn More on Larimar Therapeutics's short interest ratio. Is Larimar Therapeutics' short interest increasing or decreasing? Larimar Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 3,190,000 shares, an increase of 95.7% from the previous total of 1,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Larimar Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Larimar Therapeutics: ADC Therapeutics SA (1.81%), Lexicon Pharmaceuticals, Inc. (8.90%), Avid Bioservices, Inc. (15.99%), Neurogene Inc. (7.87%), Annexon, Inc. (3.99%), Corbus Pharmaceuticals Holdings, Inc. (4.58%), Esperion Therapeutics, Inc. (11.82%), Biomea Fusion, Inc. (47.76%), Organogenesis Holdings Inc. (9.35%), Entrada Therapeutics, Inc. (9.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Larimar Therapeutics stock? Short selling LRMR is an investing strategy that aims to generate trading profit from Larimar Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Larimar Therapeutics? A short squeeze for Larimar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LRMR, which in turn drives the price of the stock up even further. How often is Larimar Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LRMR, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ADCT Short Interest Data LXRX Short Interest Data CDMO Short Interest Data NGNE Short Interest Data ANNX Short Interest Data CRBP Short Interest Data ESPR Short Interest Data BMEA Short Interest Data ORGO Short Interest Data TRDA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LRMR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry